These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12566993)

  • 1. Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: tetramer assay and therapeutic implications.
    Tsai SL; Sheen IS; Chien RN; Chu CM; Huang HC; Chuang YL; Lee TH; Liao SK; Lin CL; Kuo GC; Liaw YF
    J Biomed Sci; 2003; 10(1):120-35. PubMed ID: 12566993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL.
    Zhu F; Eckels DD
    Hum Immunol; 2002 Sep; 63(9):710-8. PubMed ID: 12175725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusion protein of tapasin and hepatitis B core antigen 18‑27 enhances T helper cell type 1/2 cytokine ratio and antiviral immunity by inhibiting suppressors of cytokine signaling family members 1/3 in hepatitis B virus transgenic mice.
    Tang Y; Chen X; Zhang Y; Tang Z; Zhuo M; Li D; Wang P; Zang G; Yu Y
    Mol Med Rep; 2014 Apr; 9(4):1171-8. PubMed ID: 24535102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses.
    Hultgren C; Milich DR; Weiland O; Sällberg M
    J Gen Virol; 1998 Oct; 79 ( Pt 10)():2381-91. PubMed ID: 9780043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment.
    Tsai SL; Lee TH; Chien RN; Liao SK; Lin CL; Kuo GC; Liaw YF
    J Immunol Methods; 2004 Feb; 285(1):71-87. PubMed ID: 14871536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
    Yue M; Deng X; Zhai X; Xu K; Kong J; Zhang J; Zhou Z; Yu X; Xu X; Liu Y; Zhu D; Zhang Y
    Immunol Lett; 2013 May; 152(2):89-95. PubMed ID: 23680070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunology of HCV infection: the causes of impaired cellular immune response and the effect of antiviral treatment].
    Pár G; Berki T; Pálinkás L; Balogh P; Szereday L; Halász M; Szekeres-Barthó J; Miseta A; Hegedus G; Mózsik G; Hunyady B; Pár A
    Orv Hetil; 2006 Apr; 147(13):591-600. PubMed ID: 16623441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections.
    Ferrari C; Penna A; Bertoletti A; Cavalli A; Missale G; Lamonaca V; Boni C; Valli A; Bertoni R; Urbani S; Scognamiglio P; Fiaccadori F
    Recent Results Cancer Res; 1998; 154():330-6. PubMed ID: 10027013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell recognition of hepatitis B and C viral antigens.
    Jung MC; Diepolder HM; Pape GR
    Eur J Clin Invest; 1994 Oct; 24(10):641-50. PubMed ID: 7531642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B.
    Löhr HF; Krug S; Herr W; Weyer S; Schlaak J; Wölfel T; Gerken G; Meyer zum Büschenfelde KH
    Liver; 1998 Dec; 18(6):405-13. PubMed ID: 9869395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De-immunized and Functional Therapeutic (DeFT) versions of a long lasting recombinant alpha interferon for antiviral therapy.
    Mufarrege EF; Giorgetti S; Etcheverrigaray M; Terry F; Martin W; De Groot AS
    Clin Immunol; 2017 Mar; 176():31-41. PubMed ID: 28089609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B.
    Lin CL; Tsai SL; Lee TH; Chien RN; Liao SK; Liaw YF
    Gut; 2005 Jan; 54(1):152-61. PubMed ID: 15591521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients.
    Woitas RP; Rockstroh JK; Beier I; Jung G; Kochan B; Matz B; Brackmann HH; Sauerbruch T; Spengler U
    AIDS; 1999 Jul; 13(11):1313-22. PubMed ID: 10449283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
    Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
    Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).
    Pilli M; Zerbini A; Penna A; Orlandini A; Lukasiewicz E; Pawlotsky JM; Zeuzem S; Schalm SW; von Wagner M; Germanidis G; Lurie Y; Esteban JI; Haagmans BL; Hezode C; Lagging M; Negro F; Homburger Y; Neumann AU; Ferrari C; Missale G;
    Gastroenterology; 2007 Oct; 133(4):1132-43. PubMed ID: 17919489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay].
    Zhang HP; Yan HP; Zhang YH; Feng X; Zhao Y; Liao HY; Liu YM; Chen Y; Tan YF; Liu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug; 43(8):690-4. PubMed ID: 20021848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T-Cell Responses in Hepatitis B and C: The (HLA-) A, B, and C of Hepatitis B and C.
    Nitschke K; Luxenburger H; Kiraithe MM; Thimme R; Neumann-Haefelin C
    Dig Dis; 2016; 34(4):396-409. PubMed ID: 27170395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong CD4 Th1 responses to HIV and hepatitis C virus in HIV-infected long-term non-progressors co-infected with hepatitis C virus.
    Alatrakchi N; Di Martino V; Thibault V; Autran B;
    AIDS; 2002 Mar; 16(5):713-7. PubMed ID: 11964527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribavirin upregulates interleukin-12 receptor and induces T cell differentiation towards type 1 in chronic hepatitis C.
    Shiina M; Kobayashi K; Satoh H; Niitsuma H; Ueno Y; Shimosegawa T
    J Gastroenterol Hepatol; 2004 May; 19(5):558-64. PubMed ID: 15086600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antiviral therapy on the cellular immune response in acute hepatitis C.
    Rahman F; Heller T; Sobao Y; Mizukoshi E; Nascimbeni M; Alter H; Herrine S; Hoofnagle J; Liang TJ; Rehermann B
    Hepatology; 2004 Jul; 40(1):87-97. PubMed ID: 15239090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.